Osteoporosis with pseudoglioma: genes and variants
Explore variant evidence for Osteoporosis with pseudoglioma across 1 analyzed protein (LRP5). Linked ClinVar records include 9 pathogenic or likely pathogenic variants, 45 variants of uncertain significance and 16 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-10-15. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Osteoporosis with pseudoglioma
LRP5: Low-density lipoprotein receptor-related protein 5
It transduces canonical Wnt signals that strongly regulate bone formation and also contributes to retinal vascular development. Loss-of-function variants cause osteoporosis-pseudoglioma syndrome, while activating variants cause high-bone-mass disorders.
9 ClinVar pathogenic / likely pathogenic and 61 uncertain variants in LRP5 have source records linked to Osteoporosis with pseudoglioma. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Osteoporosis with pseudoglioma
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| LRP5 R494Q | 494 | LDL-receptor class B 8 | Pathogenic / likely pathogenic (★★) |
| LRP5 R494W | 494 | LDL-receptor class B 8 | Pathogenic / likely pathogenic (★★) |
| LRP5 R353Q | 353 | Beta-propeller 2 | Pathogenic / likely pathogenic (★★) |
| LRP5 M791V | 791 | LDL-receptor class B 13 | Pathogenic / likely pathogenic (★) |
| LRP5 Y776S | 776 | LDL-receptor class B 13 | Pathogenic / likely pathogenic (★) |
| LRP5 D381G | 381 | Beta-propeller 2 | Pathogenic / likely pathogenic (★) |
| LRP5 T244M | 244 | LDL-receptor class B 4 | Pathogenic / likely pathogenic |
| LRP5 L145F | 145 | LDL-receptor class B 2 | Pathogenic / likely pathogenic |
| LRP5 D69Y | 69 | Beta-propeller 1 | Pathogenic / likely pathogenic |
Which prediction tools work for Osteoporosis with pseudoglioma
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- AlphaMissense: 98 out of 100
- PolyPhen-2: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 95 out of 100
- SIFT: 93 out of 100
Same protein, different disease
- Exudative vitreoretinopathy also has ClinVar records linked to LRP5 variants; they fall mostly in different places as the Osteoporosis with pseudoglioma variants (17 pathogenic / likely pathogenic).
- Worth disease also has ClinVar records linked to LRP5 variants; they fall mostly in different places as the Osteoporosis with pseudoglioma variants (9 pathogenic / likely pathogenic).
- Autosomal dominant osteopetrosis also has ClinVar records linked to LRP5 variants; they fall mostly in different places as the Osteoporosis with pseudoglioma variants (6 pathogenic / likely pathogenic).
- Polycystic liver disease 4 with or without kidney cysts also has ClinVar records linked to LRP5 variants; they fall mostly in different places as the Osteoporosis with pseudoglioma variants (6 pathogenic / likely pathogenic).
- Bone mineral density quantitative trait locus 1 also has ClinVar records linked to LRP5 variants; they fall mostly in different places as the Osteoporosis with pseudoglioma variants (5 pathogenic / likely pathogenic).
Diseases related to Osteoporosis with pseudoglioma
- Osteogenesis imperfecta, also linked to LRP5
- Exudative vitreoretinopathy, also linked to LRP5
- Worth disease, also linked to LRP5
- Osteoporosis, also linked to LRP5
- Autosomal dominant osteopetrosis, also linked to LRP5
- Polycystic liver disease 4 with or without kidney cysts, also linked to LRP5
- Bone mineral density quantitative trait locus 1, also linked to LRP5
- Postmenopausal osteoporosis, also linked to LRP5
- Autosomal dominant polycystic liver disease, also linked to LRP5
- Skeletal dysplasia, also linked to LRP5
- Familial exudative vitreoretinopathy, also linked to LRP5
Frequently asked questions
Which genes have records linked to Osteoporosis with pseudoglioma?
This view contains 1 analyzed proteins: LRP5. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 9 pathogenic or likely pathogenic variants, 45 variants of uncertain significance and 16 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 70 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center